![Amer Zeidan: Nothing is better than training international students on research](https://oncodaily.com/pub/uploads/2024/06/IMG_3313-e1718541408445.jpeg)
Amer Zeidan: Nothing is better than training international students on research
Amer Zeidan shared a post on X:
“Nothing better training international students on research.
True pleasure to work with graduating Jordan University medical student Abdulrahman Alhajahjeh on 2 projects related to disparities of opening leukemia trials in low income countries and predictors of early trial termination.”
Source: Amer Zeidan/X
Amer Zeidan is an Associate Professor of Medicine (Hematology) at Yale University. He is also the medical director of Hematology Early Therapeutics Research, the leader of the Myeloid Malignancies DART (Disease Aligned Research Team), and the director of Continuing Medical Education (CME) at the Hematology division and chairs the Protocol Review Committee (PRC) at Yale Cancer Center. Dr. Zeidan is a well-known leukemia researcher with a special focus on targeted therapies and immunotherapy for myeloid malignancies, and a social media influencer in the field of blood cancer.